Advertisement

Topics

CRT and Merck extend partnership to discover new cancer drugs

19:00 EDT 29 Jun 2017 | Pharmaceutical Technology

UK-based Cancer Research Technology (CRT) has extended its collaboration with US pharmaceutical company Merck to discover new cancer drugs targeting the Hippo pathway.

Original Article: CRT and Merck extend partnership to discover new cancer drugs

NEXT ARTICLE

More From BioPortfolio on "CRT and Merck extend partnership to discover new cancer drugs"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...